These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15639720)

  • 1. Anticoagulant drugs increase natural killer cell activity in lung cancer.
    Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
    Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
    Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of adhesion breast cancer cells by anticoagulant drugs and cimetidine.
    Bobek V; Boubelik M; Kovarík J; Taltynov O
    Neoplasma; 2003; 50(2):148-51. PubMed ID: 12740651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
    Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
    Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
    Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of surgical treatment on the natural killer activity in lung cancer patients].
    Ancheva M; Boeva M; Tenev V
    Eksp Onkol; 1989; 11(2):39-41. PubMed ID: 2737129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
    Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
    Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the decreased NK (natural killer) activity in lung cancer patients, using whole blood versus separated mononuclear cells.
    Nielsen LR; Kimose HH; Linnet L; Møller NP; Bukh A
    J Clin Lab Immunol; 1989 Jun; 29(2):71-7. PubMed ID: 2632804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
    Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12-mediated killer activity in lung cancer patients.
    Haku T; Yanagawa H; Nabioullin R; Takeuchi E; Sone S
    Cytokine; 1997 Nov; 9(11):846-52. PubMed ID: 9367545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.
    Whitson BA; D'Cunha J; Andrade RS; Kelly RF; Groth SS; Wu B; Miller JS; Kratzke RA; Maddaus MA
    Ann Thorac Surg; 2008 Dec; 86(6):1735-44. PubMed ID: 19021967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.
    Yoshitomi Y; Nakanishi H; Kusano Y; Munesue S; Oguri K; Tatematsu M; Yamashina I; Okayama M
    Cancer Lett; 2004 Apr; 207(2):165-74. PubMed ID: 15072825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of local hyperthermia on NK activity and lung metastasis in mice].
    Hu Y; Wang J; Lu S
    Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):582-4. PubMed ID: 9275469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.